Theravance Biopharma, Inc. (21) | Business Operations (5)
Browse by Subcategory
Recent Contracts
-
Settlement Agreement by and between Ann Brady and Theravance Biopharma Ireland Limited, dated November 2, 2021
(Filed With SEC on February 28, 2022)
-
Development and Commercialization Agreement by and between Theravance Biopharma R&D, Inc. and Mylan Ireland Limited, dated January 30, 2015
(Filed With SEC on February 26, 2021)
-
License and Collaboration Agreement by and between Theravance Biopharma Ireland Limited and Janssen Biotech, Inc. dated as of February 5, 2018
(Filed With SEC on February 26, 2021)
-
Cooperation Agreement among Theravance Biopharma, Inc., GSK Finance (No.3) plc and GlaxoSmithKline plc dated June 22, 2020
(Filed With SEC on June 25, 2020)
-
Amendment No. 1 to the Development and Commercialization Agreement by and between Theravance Biopharma Ireland Limited and Mylan Ireland Limited, dated June 12, 2019
(Filed With SEC on August 5, 2019)